Openbookopenbook
Equity
DOCS
+0.0 · +0.00%
USD · NYSE

Doximity Inc(DOCS) Stock Analysis | Healthcare

USD --+0.00%
Reward72High
Risk45Moderate
75%Data
Strong 25% profit margin
Quality Compounder
Market Cap:4.51Bn
ⓘ
Reward Rating
72
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
45
Moderate
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on DOCS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for DOCS, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $29.78.

What is Doximity Inc?

operates a digital platform for medical professionals in the United States.

DOCS · Verdict

Strong reward · moderate risk

DOCS stands out on balance sheet and cash flow, but watch the volatility signal.

Based on 88% data coverage

DOCS · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet100/100

    Current ratio 6.09

  • Cash flow95/100

    49% free-cash-flow margin

  • Profitability93/100

    30% net margin · 17% ROE

  • Growth74/100

    Rev +15.5% CAGR · earnings +20.2%

  • Valuation74/100

    P/E 18.8× · PEG 0.59

Watchouts 1

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Doximity Inc?

operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 4.51B, and a P/E ratio of 30.2x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (72)

The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Health Information Services names that are close enough in size to make side-by-side comparison useful.

HTFLMid Cap / 4.3B market cap
Heartflow, Inc. Common Stock
Compare
WAYMid Cap / 4.8B market cap
Waystar Holding Corp. Common Stock
Compare
PANHFMid Cap / 5.2B market cap
Ping An Healthcare and Technology Company Limited
Compare
Company Information
SectorHealthcare
IndustryHealth Information Services
Market Cap4.51B
P/E Ratio30.1548
Dividend YieldN/A
Beta1.212
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
36,746 shares
$162k
0
6-9months
12,282 shares
$64k
0
9-12months
432,000 shares
$2.3M
0
1 disclosure without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.